Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
NCT02907749
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Cirrhosis
Portal Hypertension
Interventions
DRUG:
Spironolactone and carvedilol
DRUG:
Carvedilol
Sponsor
Changqing Yang